Citation: F. Amant, The misoprostal third stage study: a randomised controlled comparison between orally administered misoprostol and standard management - A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage labour, BR J OBST G, 108(3), 2001, pp. 338-338
Authors:
Amant, F
Debiec-Rychter, M
Schoenmakers, EFPM
Hagemeijer-Hausman, A
Vergote, I
Citation: F. Amant et al., Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of Pseudo-Meigs' syndrome, GENE CHROM, 32(4), 2001, pp. 324-329
Authors:
Amant, F
Dreyer, L
Makin, J
Vergote, I
Lindeque, BG
Citation: F. Amant et al., Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations, EUR J GYN O, 22(3), 2001, pp. 194-200
Authors:
Amant, F
Gabriel, C
Timmerman, D
Vergote, I
Citation: F. Amant et al., Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyomawith elevated CA 125, GYNECOL ONC, 83(1), 2001, pp. 153-157
Authors:
Amant, F
Spitz, B
Timmerman, D
Corremans, A
Van Assche, FA
Citation: F. Amant et al., Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial, BR J OBST G, 106(10), 1999, pp. 1066-1070
Authors:
de Jonge, ETM
Viljoen, E
Lindeque, BG
Amant, F
Nesland, JM
Holm, R
Citation: Etm. De Jonge et al., The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy, INT J GYN C, 9(3), 1999, pp. 198-205
Authors:
Timmerman, D
Schwarzler, P
Collins, WP
Claerhout, F
Coenen, M
Amant, F
Vergote, I
Bourne, TH
Citation: D. Timmerman et al., Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience, ULTRASOUN O, 13(1), 1999, pp. 11-16
Citation: F. Amant et al., Gastrostomy using a "Gastrofix" as an alternative for nasogastric tubes inovarian cancer surgery, GYNECOL ONC, 71(3), 1998, pp. 348-351